Medicare Enrolled
Dr. Hashim Gazi, M.D.
Interventional Cardiology · Tarzana, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Research-focused
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gazi
Dr. Hashim Gazi is an interventional cardiology specialist in Tarzana, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Gazi performed 1,904 Medicare services across 1,285 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gazi received a total of $47,533 from 24 pharmaceutical and/or device companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ 1,904 Medicare services
$47,533 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,904
Medicare services
Bottom 43% in CA for interventional cardiology
1,285
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
348 | $48 | $168 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
277 | $76 | $276 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
250 | $106 | $378 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
173 | $67 | $227 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
145 | $56 | $215 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
142 | $398 | $1,386 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
106 | $146 | $497 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $135 | $489 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
70 | $172 | $610 |
| Cardiac catheterization | 58 | $191 | $807 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
36 | $434 | $1,607 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
28 | $78 | $260 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
27 | $11 | $38 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
26 | $18 | $61 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
26 | $22 | $74 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
25 | $12 | $40 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $21 | $71 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
19 | $3 | $9 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
16 | $60 | $199 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
15 | $91 | $304 |
| Ultrasound of heart An imaging test that uses sound waves to create pictures of the heart's structure and function. |
11 | $37 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.6% high complexity
56.4% medium
35.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$47,533
Total received (2018-2024)
Avg $6,790/year across 7 years
Top 15% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Scientific / Research
Research funding and grants
$36,447 (76.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,919 (23.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$167 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,526
2023
$366
2022
$3,233
2021
$381
2020
$17,838
2019
$21,510
2018
$2,678
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,004
ABIOMED
$208
Boston Scientific Corporation
$127
iRhythm Technologies, Inc.
$70
Biosense Webster, Inc.
$65
Novartis Pharmaceuticals Corporation
$29
E.R. Squibb & Sons, L.L.C.
$22
Top 3 companies account for 87.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$20,843
Boston Scientific Corporation
$15,791
Medtronic, Inc.
$4,161
Edwards Lifesciences Corporation
$2,289
Abbott Laboratories
$2,287
ABIOMED
$640
AstraZeneca Pharmaceuticals LP
$210
Amgen Inc.
$200
Inari Medical, Inc.
$196
PFIZER INC.
$149
Teleflex LLC
$142
Janssen Pharmaceuticals, Inc
$126
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$75
iRhythm Technologies, Inc.
$70
Biosense Webster, Inc.
$65
BOSTON SCIENTIFIC CORPORATION
$48
Cardinal Health 200, LLC
$46
Novartis Pharmaceuticals Corporation
$43
Actelion Pharmaceuticals US, Inc.
$42
Preventice Services, LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$22
Otsuka America Pharmaceutical, Inc.
$14
Amarin Pharma Inc.
$13
Top 3 companies account for 85.8% of all-time payments
Associated products mentioned in payments ›
AVALUS · Advisa · Assurity Pacemaker · BRILINTA · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · CoreValve Evolut · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Edwards SAPIEN XT Transcatheter Heart Valve · Emerge Push · FARXIGA · FLOWTRIEVER CATHETER · GENERAL STENTS · GENERAL - ATHERECTOMY · GENERAL - STENTS · GENERAL - STRUCTURAL HEART · Impella · JARDIANCE · JYNARQUE · LifeVest · MAMBA · MICRA · Manta · Merlin Connectivity and Remote · MitraClip System · Mozec NC PTCA Balloon · NUVISION ICE CATHETER · OPSUMIT · Pacemakers · Repatha · S · SYNERGY · TYRX · Tendril Pacing Lead · UPTRAVI · Vascepa · WATCHMAN Access System · XARELTO · XIENCE SIERRA · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.
Geographic Context
Interventional cardiologists within 10 mi
71
Per 100K population
0.7
County median income
$87,760
Nearest hospital
PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gazi is a cardiac imaging specialist, with moderate Medicare volume, with research-focused industry engagement in the top 15% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gazi experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Gazi performed 348 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gazi receive payments from pharmaceutical companies?
Yes. Dr. Gazi received a total of $47,533 from 24 companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gazi's costs compare to other interventional cardiologists in Tarzana?
Dr. Gazi's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Tarzana
Browse interventional cardiologists in Tarzana ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology